H.C. Wainwright Reiterates Buy Rating on Citius Pharmaceuticals (CTXR)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- US stock futures muted as oil holds near April highs ahead of Fed decision
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
| (NASDAQ: CTXR) | Delayed: 0.45 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.45 | 52 Week High | $2.50 | |||
| Open | $0.45 | 52 Week Low | $0.40 | |||
| Day High | $0.45 | P/E | N/A | |||
| Day Low | $0.45 | EPS | $0.00 | |||
| Volume | 2 | |||||
